Purchase Order 75N95024P00403
- Not listed
- This federal contract award was issued by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, to Promega Corporation, a global life sciences company. The $24,241.50 Blanket Purchase Agreement (BPA) call task order is for the delivery of multiple reagent kits and assays. This order is part of a larger $11.5 million BPA that Promega holds with the Defense Health Agency for DNA analysis systems, forensic...
- The National Center for Advancing Translational Sciences, a civilian agency within the U.S. Department of Health and Human Services, awarded a Firm Fixed Price Purchase Order contract to Promega Corporation, a for-profit manufacturer of biological research and diagnostic products. The $66,970.35 contract is for the delivery of Promega's proprietary laboratory equipment, reagents, and consumables to support the agency's biomedical research and testing programs. This award is under a $10 million...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a firm fixed price purchase order contract to Promega Corporation, a global life sciences company, for the provision of reagent kits and assays. The contract has a potential value of $22,784.00 and a completion date of July 21, 2020. Promega has previously provided DNA analysis equipment, reagents, assays, and related laboratory supplies to federal agencies...
- This is a $127,908.40 firm fixed-price purchase order awarded to Promega Corporation, a global life sciences company, by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). The award is for Promega's proprietary reagent kits and assay products, which are sole source procured due to their specialized capabilities required to support NCATS' ongoing laboratory research and high-throughput screening programs. This award was not...
- This firm-fixed-price purchase order was awarded to Promega Corporation, a global life sciences company, by the National Center for Advancing Translational Sciences (NCATS) within the Department of Health and Human Services' National Institutes of Health. The $121,492.50 contract is for the procurement of detection assay systems with an August 2021 completion date. Promega has previously been awarded prime and subcontracts by various agencies including the NIH, CDC, DoD, and FBI to provide DNA...
- This is a $18,439.20 firm fixed-price purchase order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Promega Corporation, a large for-profit manufacturer. The contract is not set aside for small businesses. Promega provides specialized laboratory equipment, reagents, and assays to support critical scientific research, diagnostic testing, and forensic applications across various federal agencies such as the NIH, CDC, DoD, and FBI. This...
- This federal contract award is to Promega Corporation, a global life sciences company that develops, manufactures, and markets integrated systems and reagents used for biological research and molecular diagnostics. The $186,036 firm fixed-price purchase order was issued by the National Institute on Drug Abuse, part of the Department of Health and Human Services' National Institutes of Health. The contract, which does not have a set-aside designation, is for the delivery of DNA analysis...
- This is a firm fixed-price BPA call contract awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Promega Corporation, a global life sciences company. The $7,477 contract is for the delivery of various laboratory equipment, reagents, and services used to support biomedical research and testing programs across federal agencies. The contract is part of a larger $11.5 million Blanket Purchase Agreement Promega holds with the Defense...
- This is a $338,521.70 definitive contract awarded by the National Institute on Drug Abuse, a civilian agency under the Department of Health and Human Services, to Promega Corporation, a large business manufacturer of life science reagents and equipment. The contract, which has a fixed price, is for the provision of PROMEGA REAGENTS to support the National Center for Advancing Translational Sciences (NCATS) program. The contract does not utilize a set-aside designation. Promega has several...
- This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) on behalf of the National Center for Advancing Translational Sciences (NCATS) to Promega Corporation, a global life sciences company. The $83,800 contract is for the procurement of Promega reagents and assays to support NCATS' Antiviral Program for Pandemics. The award does not utilize a set-aside designation. The original solicitation states that NCATS' screening assays have been optimized using Promega...
This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services. The $86,800.00 contract is for Promega Corporation, a global life sciences company, to provide reagent kits and assays. The award is not set aside for any small business designations. Promega holds several significant federal contract vehicles, including Blanket Purchase Agreements with the Defense Health Agency and the National Institutes of Health, as well as an indefinite delivery contract with the Federal Bureau of Investigation. Through these contracts, Promega supplies a variety of life science research products and services to support the missions of civilian and defense agencies engaged in medical research, healthcare, and forensic analysis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $86.8k | 7/30/24 |